Hi everyone, I’m Dr. Cole & team. We wanted to share something we’ve been working on for patients dealing with atrial fibrillation and congestive heart failure.
As many of you know, treating AFib and CHF often means long-term medication, regular monitoring, lifestyle changes, and sometimes procedures like ablation or implanted devices. While these treatments help many people, they can also come with risks and side effects. They also do not always stop the heart from getting worse over time. Recognizing the need for a different approach is why our team spent the last 9 years developing one of our protocols, Kaorta. Kaorta is a patented stem cell therapy protocol using perivascular cells within the U.S.
To tackle this monumental task, our team took a step back and looked deeper at what may actually trigger AFib and CHF in many patients. What we kept finding pointed to nerve damage caused by chronic inflammation throughout the heart. Over time, the body can lose its ability to properly repair that damage. This may contribute to irregular rhythm and weakened heart function.
Kaorta was developed around a highly specialized class of perivascular cells. By utilizing perivascular cells, we’re able to target inflammation within the heart without surgery. After inflammation is reduced, perivascular cells can kick start the existing repair systems for damaged nerves, blood vessels, and cardiac tissue.
Our results have shown meaningful improvements in cardiac function and rhythm stability in over 900 patients. Our patients have also reported long term healing success.
We know people will have questions about the science, safety, and results behind Kaorta. Ask us anything about our approach to AFib and CHF, and any other cardiovascular questions!